nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pons—multiple sclerosis	0.0442	0.207	CbGeAlD
Nedocromil—HSP90AA1—pineal body—multiple sclerosis	0.0316	0.147	CbGeAlD
Nedocromil—FPR1—nervous system—multiple sclerosis	0.0142	0.0664	CbGeAlD
Nedocromil—FPR1—central nervous system—multiple sclerosis	0.0137	0.064	CbGeAlD
Nedocromil—PTGDR—nervous system—multiple sclerosis	0.0134	0.0627	CbGeAlD
Nedocromil—PTGDR—central nervous system—multiple sclerosis	0.0129	0.0604	CbGeAlD
Nedocromil—PTGDR—brain—multiple sclerosis	0.0103	0.0479	CbGeAlD
Nedocromil—HSP90AA1—brainstem—multiple sclerosis	0.00984	0.046	CbGeAlD
Nedocromil—HSP90AA1—retina—multiple sclerosis	0.00949	0.0444	CbGeAlD
Nedocromil—HSP90AA1—medulla oblongata—multiple sclerosis	0.00686	0.0321	CbGeAlD
Nedocromil—HSP90AA1—midbrain—multiple sclerosis	0.00627	0.0293	CbGeAlD
Nedocromil—HSP90AA1—spinal cord—multiple sclerosis	0.00612	0.0286	CbGeAlD
Nedocromil—CYSLTR1—nervous system—multiple sclerosis	0.00594	0.0278	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—multiple sclerosis	0.00572	0.0267	CbGeAlD
Nedocromil—Gastroenteritis—Fingolimod—multiple sclerosis	0.00554	0.026	CcSEcCtD
Nedocromil—Eczema—Fingolimod—multiple sclerosis	0.00547	0.0257	CcSEcCtD
Nedocromil—HSP90AA1—nervous system—multiple sclerosis	0.00516	0.0241	CbGeAlD
Nedocromil—Rash erythematous—Cladribine—multiple sclerosis	0.00501	0.0235	CcSEcCtD
Nedocromil—HSP90AA1—central nervous system—multiple sclerosis	0.00496	0.0232	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—multiple sclerosis	0.00485	0.0227	CbGeAlD
Nedocromil—CYSLTR1—brain—multiple sclerosis	0.00454	0.0212	CbGeAlD
Nedocromil—Influenza—Fingolimod—multiple sclerosis	0.00425	0.0199	CcSEcCtD
Nedocromil—Bronchitis—Fingolimod—multiple sclerosis	0.00408	0.0192	CcSEcCtD
Nedocromil—HSP90AA1—brain—multiple sclerosis	0.00394	0.0184	CbGeAlD
Nedocromil—Pneumonia—Fingolimod—multiple sclerosis	0.00381	0.0179	CcSEcCtD
Nedocromil—Sinusitis—Fingolimod—multiple sclerosis	0.00355	0.0167	CcSEcCtD
Nedocromil—Arthritis—Cladribine—multiple sclerosis	0.00287	0.0135	CcSEcCtD
Nedocromil—Viral infection—Mitoxantrone—multiple sclerosis	0.00279	0.0131	CcSEcCtD
Nedocromil—Leukopenia—Fingolimod—multiple sclerosis	0.00265	0.0124	CcSEcCtD
Nedocromil—Cough—Fingolimod—multiple sclerosis	0.00258	0.0121	CcSEcCtD
Nedocromil—Stinging—Prednisolone—multiple sclerosis	0.00255	0.012	CcSEcCtD
Nedocromil—Eosinophilia—Cladribine—multiple sclerosis	0.00238	0.0112	CcSEcCtD
Nedocromil—Stinging—Triamcinolone—multiple sclerosis	0.00235	0.011	CcSEcCtD
Nedocromil—Viral infection—Prednisolone—multiple sclerosis	0.00229	0.0108	CcSEcCtD
Nedocromil—Rash erythematous—Dexamethasone—multiple sclerosis	0.00225	0.0106	CcSEcCtD
Nedocromil—Rash erythematous—Betamethasone—multiple sclerosis	0.00225	0.0106	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00224	0.0105	CcSEcCtD
Nedocromil—Pneumonia—Cladribine—multiple sclerosis	0.00216	0.0101	CcSEcCtD
Nedocromil—Dyspnoea—Fingolimod—multiple sclerosis	0.00215	0.0101	CcSEcCtD
Nedocromil—Stinging—Dexamethasone—multiple sclerosis	0.00213	0.01	CcSEcCtD
Nedocromil—Stinging—Betamethasone—multiple sclerosis	0.00213	0.01	CcSEcCtD
Nedocromil—Conjunctivitis—Cladribine—multiple sclerosis	0.00209	0.00979	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00208	0.00979	CcSEcCtD
Nedocromil—Fatigue—Fingolimod—multiple sclerosis	0.00208	0.00977	CcSEcCtD
Nedocromil—Cough increased—Triamcinolone—multiple sclerosis	0.00208	0.00976	CcSEcCtD
Nedocromil—Pharyngitis—Cladribine—multiple sclerosis	0.00191	0.00898	CcSEcCtD
Nedocromil—Pneumonia—Azathioprine—multiple sclerosis	0.00176	0.00824	CcSEcCtD
Nedocromil—Asthenia—Fingolimod—multiple sclerosis	0.00173	0.00813	CcSEcCtD
Nedocromil—Viral infection—Prednisone—multiple sclerosis	0.00166	0.00781	CcSEcCtD
Nedocromil—Diarrhoea—Fingolimod—multiple sclerosis	0.00165	0.00776	CcSEcCtD
Nedocromil—Dizziness—Fingolimod—multiple sclerosis	0.0016	0.0075	CcSEcCtD
Nedocromil—Headache—Fingolimod—multiple sclerosis	0.00151	0.0071	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00147	0.0069	CcSEcCtD
Nedocromil—Cough—Cladribine—multiple sclerosis	0.00146	0.00687	CcSEcCtD
Nedocromil—Chest pain—Cladribine—multiple sclerosis	0.00143	0.0067	CcSEcCtD
Nedocromil—Pneumonia—Mitoxantrone—multiple sclerosis	0.00142	0.00666	CcSEcCtD
Nedocromil—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.00137	0.00644	CcSEcCtD
Nedocromil—Sinusitis—Mitoxantrone—multiple sclerosis	0.00132	0.00621	CcSEcCtD
Nedocromil—Rhinitis—Mitoxantrone—multiple sclerosis	0.00127	0.00596	CcSEcCtD
Nedocromil—Pharyngitis—Mitoxantrone—multiple sclerosis	0.00126	0.0059	CcSEcCtD
Nedocromil—Leukopenia—Azathioprine—multiple sclerosis	0.00122	0.00573	CcSEcCtD
Nedocromil—Dyspnoea—Cladribine—multiple sclerosis	0.00122	0.00573	CcSEcCtD
Nedocromil—Influenza—Triamcinolone—multiple sclerosis	0.00119	0.0056	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00118	0.00555	CcSEcCtD
Nedocromil—Fatigue—Cladribine—multiple sclerosis	0.00118	0.00554	CcSEcCtD
Nedocromil—Pain—Cladribine—multiple sclerosis	0.00117	0.00549	CcSEcCtD
Nedocromil—Bronchitis—Triamcinolone—multiple sclerosis	0.00115	0.00539	CcSEcCtD
Nedocromil—Conjunctivitis—Prednisolone—multiple sclerosis	0.00113	0.00528	CcSEcCtD
Nedocromil—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00112	0.00525	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00111	0.00521	CcSEcCtD
Nedocromil—Urticaria—Cladribine—multiple sclerosis	0.00109	0.0051	CcSEcCtD
Nedocromil—Body temperature increased—Cladribine—multiple sclerosis	0.00108	0.00508	CcSEcCtD
Nedocromil—Abdominal pain—Cladribine—multiple sclerosis	0.00108	0.00508	CcSEcCtD
Nedocromil—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00108	0.00507	CcSEcCtD
Nedocromil—Conjunctivitis—Triamcinolone—multiple sclerosis	0.00103	0.00486	CcSEcCtD
Nedocromil—Hypersensitivity—Cladribine—multiple sclerosis	0.00101	0.00473	CcSEcCtD
Nedocromil—Visual impairment—Prednisolone—multiple sclerosis	0.001	0.0047	CcSEcCtD
Nedocromil—Leukopenia—Mitoxantrone—multiple sclerosis	0.000987	0.00463	CcSEcCtD
Nedocromil—Asthenia—Cladribine—multiple sclerosis	0.000982	0.00461	CcSEcCtD
Nedocromil—Cough—Mitoxantrone—multiple sclerosis	0.000962	0.00452	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000961	0.00451	CcSEcCtD
Nedocromil—Rhinitis—Triamcinolone—multiple sclerosis	0.000958	0.0045	CcSEcCtD
Nedocromil—Rhinitis—Methylprednisolone—multiple sclerosis	0.000956	0.00449	CcSEcCtD
Nedocromil—Pharyngitis—Triamcinolone—multiple sclerosis	0.000948	0.00445	CcSEcCtD
Nedocromil—Conjunctivitis—Betamethasone—multiple sclerosis	0.000939	0.00441	CcSEcCtD
Nedocromil—Conjunctivitis—Dexamethasone—multiple sclerosis	0.000939	0.00441	CcSEcCtD
Nedocromil—Chest pain—Mitoxantrone—multiple sclerosis	0.000939	0.00441	CcSEcCtD
Nedocromil—Diarrhoea—Cladribine—multiple sclerosis	0.000937	0.0044	CcSEcCtD
Nedocromil—Visual impairment—Methylprednisolone—multiple sclerosis	0.000919	0.00431	CcSEcCtD
Nedocromil—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00091	0.00427	CcSEcCtD
Nedocromil—Dizziness—Cladribine—multiple sclerosis	0.000905	0.00425	CcSEcCtD
Nedocromil—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.0009	0.00422	CcSEcCtD
Nedocromil—Body temperature increased—Azathioprine—multiple sclerosis	0.00088	0.00413	CcSEcCtD
Nedocromil—Abdominal pain—Azathioprine—multiple sclerosis	0.00088	0.00413	CcSEcCtD
Nedocromil—Vomiting—Cladribine—multiple sclerosis	0.00087	0.00409	CcSEcCtD
Nedocromil—Rash—Cladribine—multiple sclerosis	0.000863	0.00405	CcSEcCtD
Nedocromil—Dermatitis—Cladribine—multiple sclerosis	0.000862	0.00405	CcSEcCtD
Nedocromil—Headache—Cladribine—multiple sclerosis	0.000858	0.00403	CcSEcCtD
Nedocromil—Visual impairment—Betamethasone—multiple sclerosis	0.000836	0.00392	CcSEcCtD
Nedocromil—Visual impairment—Dexamethasone—multiple sclerosis	0.000836	0.00392	CcSEcCtD
Nedocromil—Hypersensitivity—Azathioprine—multiple sclerosis	0.00082	0.00385	CcSEcCtD
Nedocromil—Dysgeusia—Triamcinolone—multiple sclerosis	0.000815	0.00382	CcSEcCtD
Nedocromil—Nausea—Cladribine—multiple sclerosis	0.000813	0.00382	CcSEcCtD
Nedocromil—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000802	0.00377	CcSEcCtD
Nedocromil—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000792	0.00372	CcSEcCtD
Nedocromil—Eosinophilia—Methotrexate—multiple sclerosis	0.000781	0.00366	CcSEcCtD
Nedocromil—Fatigue—Mitoxantrone—multiple sclerosis	0.000776	0.00364	CcSEcCtD
Nedocromil—Pain—Mitoxantrone—multiple sclerosis	0.000769	0.00361	CcSEcCtD
Nedocromil—Diarrhoea—Azathioprine—multiple sclerosis	0.000762	0.00357	CcSEcCtD
Nedocromil—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000738	0.00346	CcSEcCtD
Nedocromil—Dizziness—Azathioprine—multiple sclerosis	0.000736	0.00345	CcSEcCtD
Nedocromil—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000736	0.00345	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000733	0.00344	CcSEcCtD
Nedocromil—Cough—Triamcinolone—multiple sclerosis	0.000726	0.00341	CcSEcCtD
Nedocromil—Urticaria—Mitoxantrone—multiple sclerosis	0.000715	0.00336	CcSEcCtD
Nedocromil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000711	0.00334	CcSEcCtD
Nedocromil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000711	0.00334	CcSEcCtD
Nedocromil—Vomiting—Azathioprine—multiple sclerosis	0.000708	0.00332	CcSEcCtD
Nedocromil—Pneumonia—Methotrexate—multiple sclerosis	0.000707	0.00332	CcSEcCtD
Nedocromil—Rash—Azathioprine—multiple sclerosis	0.000702	0.00329	CcSEcCtD
Nedocromil—Dermatitis—Azathioprine—multiple sclerosis	0.000701	0.00329	CcSEcCtD
Nedocromil—Headache—Azathioprine—multiple sclerosis	0.000697	0.00327	CcSEcCtD
Nedocromil—Dry mouth—Triamcinolone—multiple sclerosis	0.000693	0.00325	CcSEcCtD
Nedocromil—Conjunctivitis—Methotrexate—multiple sclerosis	0.000683	0.00321	CcSEcCtD
Nedocromil—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000679	0.00319	CcSEcCtD
Nedocromil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000677	0.00318	CcSEcCtD
Nedocromil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000663	0.00311	CcSEcCtD
Nedocromil—Nausea—Azathioprine—multiple sclerosis	0.000661	0.0031	CcSEcCtD
Nedocromil—Asthenia—Mitoxantrone—multiple sclerosis	0.000646	0.00303	CcSEcCtD
Nedocromil—Pain—Prednisolone—multiple sclerosis	0.000631	0.00296	CcSEcCtD
Nedocromil—Pharyngitis—Methotrexate—multiple sclerosis	0.000626	0.00294	CcSEcCtD
Nedocromil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000616	0.00289	CcSEcCtD
Nedocromil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000616	0.00289	CcSEcCtD
Nedocromil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000616	0.00289	CcSEcCtD
Nedocromil—Visual impairment—Methotrexate—multiple sclerosis	0.000608	0.00285	CcSEcCtD
Nedocromil—Dyspnoea—Triamcinolone—multiple sclerosis	0.000605	0.00284	CcSEcCtD
Nedocromil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000598	0.0028	CcSEcCtD
Nedocromil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000596	0.0028	CcSEcCtD
Nedocromil—Urticaria—Prednisolone—multiple sclerosis	0.000586	0.00275	CcSEcCtD
Nedocromil—Fatigue—Triamcinolone—multiple sclerosis	0.000585	0.00275	CcSEcCtD
Nedocromil—Fatigue—Methylprednisolone—multiple sclerosis	0.000584	0.00274	CcSEcCtD
Nedocromil—Pain—Triamcinolone—multiple sclerosis	0.000581	0.00272	CcSEcCtD
Nedocromil—Vomiting—Mitoxantrone—multiple sclerosis	0.000572	0.00269	CcSEcCtD
Nedocromil—Rash—Mitoxantrone—multiple sclerosis	0.000567	0.00266	CcSEcCtD
Nedocromil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000567	0.00266	CcSEcCtD
Nedocromil—Headache—Mitoxantrone—multiple sclerosis	0.000564	0.00265	CcSEcCtD
Nedocromil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000554	0.0026	CcSEcCtD
Nedocromil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000544	0.00255	CcSEcCtD
Nedocromil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000542	0.00254	CcSEcCtD
Nedocromil—Dyspepsia—Betamethasone—multiple sclerosis	0.000542	0.00254	CcSEcCtD
Nedocromil—Urticaria—Triamcinolone—multiple sclerosis	0.000539	0.00253	CcSEcCtD
Nedocromil—Urticaria—Methylprednisolone—multiple sclerosis	0.000538	0.00253	CcSEcCtD
Nedocromil—Dysgeusia—Methotrexate—multiple sclerosis	0.000538	0.00252	CcSEcCtD
Nedocromil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000537	0.00252	CcSEcCtD
Nedocromil—Anaphylactic shock—Prednisone—multiple sclerosis	0.000536	0.00252	CcSEcCtD
Nedocromil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000535	0.00251	CcSEcCtD
Nedocromil—Nausea—Mitoxantrone—multiple sclerosis	0.000534	0.00251	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000532	0.0025	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000532	0.0025	CcSEcCtD
Nedocromil—Fatigue—Betamethasone—multiple sclerosis	0.000531	0.00249	CcSEcCtD
Nedocromil—Fatigue—Dexamethasone—multiple sclerosis	0.000531	0.00249	CcSEcCtD
Nedocromil—Pain—Betamethasone—multiple sclerosis	0.000527	0.00247	CcSEcCtD
Nedocromil—Pain—Dexamethasone—multiple sclerosis	0.000527	0.00247	CcSEcCtD
Nedocromil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000504	0.00236	CcSEcCtD
Nedocromil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000504	0.00236	CcSEcCtD
Nedocromil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.0005	0.00235	CcSEcCtD
Nedocromil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000499	0.00234	CcSEcCtD
Nedocromil—Leukopenia—Methotrexate—multiple sclerosis	0.000492	0.00231	CcSEcCtD
Nedocromil—Urticaria—Betamethasone—multiple sclerosis	0.000489	0.0023	CcSEcCtD
Nedocromil—Urticaria—Dexamethasone—multiple sclerosis	0.000489	0.0023	CcSEcCtD
Nedocromil—Dizziness—Prednisolone—multiple sclerosis	0.000488	0.00229	CcSEcCtD
Nedocromil—Asthenia—Triamcinolone—multiple sclerosis	0.000487	0.00229	CcSEcCtD
Nedocromil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000487	0.00229	CcSEcCtD
Nedocromil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000487	0.00229	CcSEcCtD
Nedocromil—Abdominal pain—Betamethasone—multiple sclerosis	0.000487	0.00229	CcSEcCtD
Nedocromil—Body temperature increased—Betamethasone—multiple sclerosis	0.000487	0.00229	CcSEcCtD
Nedocromil—Asthenia—Methylprednisolone—multiple sclerosis	0.000486	0.00228	CcSEcCtD
Nedocromil—Cough—Methotrexate—multiple sclerosis	0.000479	0.00225	CcSEcCtD
Nedocromil—Dyspepsia—Prednisone—multiple sclerosis	0.000472	0.00222	CcSEcCtD
Nedocromil—Chest pain—Methotrexate—multiple sclerosis	0.000468	0.0022	CcSEcCtD
Nedocromil—Rash—Prednisolone—multiple sclerosis	0.000465	0.00218	CcSEcCtD
Nedocromil—Dermatitis—Prednisolone—multiple sclerosis	0.000465	0.00218	CcSEcCtD
Nedocromil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000463	0.00218	CcSEcCtD
Nedocromil—Fatigue—Prednisone—multiple sclerosis	0.000462	0.00217	CcSEcCtD
Nedocromil—Headache—Prednisolone—multiple sclerosis	0.000462	0.00217	CcSEcCtD
Nedocromil—Dizziness—Triamcinolone—multiple sclerosis	0.000449	0.00211	CcSEcCtD
Nedocromil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000448	0.0021	CcSEcCtD
Nedocromil—Dizziness—Methylprednisolone—multiple sclerosis	0.000448	0.0021	CcSEcCtD
Nedocromil—Asthenia—Dexamethasone—multiple sclerosis	0.000442	0.00207	CcSEcCtD
Nedocromil—Asthenia—Betamethasone—multiple sclerosis	0.000442	0.00207	CcSEcCtD
Nedocromil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000439	0.00206	CcSEcCtD
Nedocromil—Nausea—Prednisolone—multiple sclerosis	0.000438	0.00206	CcSEcCtD
Nedocromil—Vomiting—Triamcinolone—multiple sclerosis	0.000432	0.00203	CcSEcCtD
Nedocromil—Vomiting—Methylprednisolone—multiple sclerosis	0.000431	0.00202	CcSEcCtD
Nedocromil—Rash—Triamcinolone—multiple sclerosis	0.000428	0.00201	CcSEcCtD
Nedocromil—Dermatitis—Triamcinolone—multiple sclerosis	0.000428	0.00201	CcSEcCtD
Nedocromil—Rash—Methylprednisolone—multiple sclerosis	0.000427	0.002	CcSEcCtD
Nedocromil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000427	0.002	CcSEcCtD
Nedocromil—Urticaria—Prednisone—multiple sclerosis	0.000426	0.002	CcSEcCtD
Nedocromil—Headache—Triamcinolone—multiple sclerosis	0.000425	0.002	CcSEcCtD
Nedocromil—Headache—Methylprednisolone—multiple sclerosis	0.000424	0.00199	CcSEcCtD
Nedocromil—Body temperature increased—Prednisone—multiple sclerosis	0.000424	0.00199	CcSEcCtD
Nedocromil—Abdominal pain—Prednisone—multiple sclerosis	0.000424	0.00199	CcSEcCtD
Nedocromil—Diarrhoea—Betamethasone—multiple sclerosis	0.000421	0.00198	CcSEcCtD
Nedocromil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000421	0.00198	CcSEcCtD
Nedocromil—Dizziness—Dexamethasone—multiple sclerosis	0.000407	0.00191	CcSEcCtD
Nedocromil—Dizziness—Betamethasone—multiple sclerosis	0.000407	0.00191	CcSEcCtD
Nedocromil—Nausea—Triamcinolone—multiple sclerosis	0.000403	0.00189	CcSEcCtD
Nedocromil—Nausea—Methylprednisolone—multiple sclerosis	0.000402	0.00189	CcSEcCtD
Nedocromil—Dyspnoea—Methotrexate—multiple sclerosis	0.0004	0.00188	CcSEcCtD
Nedocromil—Hypersensitivity—Prednisone—multiple sclerosis	0.000395	0.00186	CcSEcCtD
Nedocromil—Dyspepsia—Methotrexate—multiple sclerosis	0.000395	0.00185	CcSEcCtD
Nedocromil—Vomiting—Dexamethasone—multiple sclerosis	0.000392	0.00184	CcSEcCtD
Nedocromil—Vomiting—Betamethasone—multiple sclerosis	0.000392	0.00184	CcSEcCtD
Nedocromil—Rash—Dexamethasone—multiple sclerosis	0.000388	0.00182	CcSEcCtD
Nedocromil—Rash—Betamethasone—multiple sclerosis	0.000388	0.00182	CcSEcCtD
Nedocromil—Dermatitis—Dexamethasone—multiple sclerosis	0.000388	0.00182	CcSEcCtD
Nedocromil—Dermatitis—Betamethasone—multiple sclerosis	0.000388	0.00182	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000387	0.00182	CcSEcCtD
Nedocromil—Fatigue—Methotrexate—multiple sclerosis	0.000387	0.00181	CcSEcCtD
Nedocromil—Headache—Betamethasone—multiple sclerosis	0.000386	0.00181	CcSEcCtD
Nedocromil—Headache—Dexamethasone—multiple sclerosis	0.000386	0.00181	CcSEcCtD
Nedocromil—Asthenia—Prednisone—multiple sclerosis	0.000385	0.00181	CcSEcCtD
Nedocromil—Pain—Methotrexate—multiple sclerosis	0.000383	0.0018	CcSEcCtD
Nedocromil—Diarrhoea—Prednisone—multiple sclerosis	0.000367	0.00172	CcSEcCtD
Nedocromil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000367	0.00172	CcSEcCtD
Nedocromil—Nausea—Betamethasone—multiple sclerosis	0.000366	0.00172	CcSEcCtD
Nedocromil—Nausea—Dexamethasone—multiple sclerosis	0.000366	0.00172	CcSEcCtD
Nedocromil—Urticaria—Methotrexate—multiple sclerosis	0.000356	0.00167	CcSEcCtD
Nedocromil—Dizziness—Prednisone—multiple sclerosis	0.000355	0.00166	CcSEcCtD
Nedocromil—Abdominal pain—Methotrexate—multiple sclerosis	0.000354	0.00166	CcSEcCtD
Nedocromil—Body temperature increased—Methotrexate—multiple sclerosis	0.000354	0.00166	CcSEcCtD
Nedocromil—Vomiting—Prednisone—multiple sclerosis	0.000341	0.0016	CcSEcCtD
Nedocromil—Rash—Prednisone—multiple sclerosis	0.000338	0.00159	CcSEcCtD
Nedocromil—Dermatitis—Prednisone—multiple sclerosis	0.000338	0.00159	CcSEcCtD
Nedocromil—Headache—Prednisone—multiple sclerosis	0.000336	0.00158	CcSEcCtD
Nedocromil—Hypersensitivity—Methotrexate—multiple sclerosis	0.00033	0.00155	CcSEcCtD
Nedocromil—Asthenia—Methotrexate—multiple sclerosis	0.000322	0.00151	CcSEcCtD
Nedocromil—Nausea—Prednisone—multiple sclerosis	0.000319	0.0015	CcSEcCtD
Nedocromil—Diarrhoea—Methotrexate—multiple sclerosis	0.000307	0.00144	CcSEcCtD
Nedocromil—Dizziness—Methotrexate—multiple sclerosis	0.000296	0.00139	CcSEcCtD
Nedocromil—Vomiting—Methotrexate—multiple sclerosis	0.000285	0.00134	CcSEcCtD
Nedocromil—Rash—Methotrexate—multiple sclerosis	0.000283	0.00133	CcSEcCtD
Nedocromil—Dermatitis—Methotrexate—multiple sclerosis	0.000282	0.00133	CcSEcCtD
Nedocromil—Headache—Methotrexate—multiple sclerosis	0.000281	0.00132	CcSEcCtD
Nedocromil—Nausea—Methotrexate—multiple sclerosis	0.000266	0.00125	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—MX1—multiple sclerosis	0.000266	0.000465	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—multiple sclerosis	0.000264	0.000461	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL3—multiple sclerosis	0.000262	0.000457	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000261	0.000455	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL10—multiple sclerosis	0.00026	0.000454	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000259	0.000451	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—POMC—multiple sclerosis	0.000258	0.00045	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-DRA—multiple sclerosis	0.000258	0.00045	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000257	0.000448	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR1—multiple sclerosis	0.000255	0.000445	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000255	0.000445	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000255	0.000445	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000255	0.000444	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTGER4—multiple sclerosis	0.000252	0.00044	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CCL2—multiple sclerosis	0.000252	0.00044	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL10—multiple sclerosis	0.000251	0.000438	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—IL6—multiple sclerosis	0.000249	0.000435	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PGR—multiple sclerosis	0.000248	0.000434	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—S1PR1—multiple sclerosis	0.000248	0.000433	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—MAPK1—multiple sclerosis	0.000245	0.000428	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCR3—multiple sclerosis	0.000244	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NOD1—multiple sclerosis	0.000243	0.000424	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GPC5—multiple sclerosis	0.000242	0.000422	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CD28—multiple sclerosis	0.000241	0.000421	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—RRM1—multiple sclerosis	0.000239	0.000418	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCR2—multiple sclerosis	0.000237	0.000414	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000237	0.000414	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MALT1—multiple sclerosis	0.000235	0.000409	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000231	0.000403	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRF5—multiple sclerosis	0.000231	0.000403	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—TYK2—multiple sclerosis	0.000229	0.000399	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD86—multiple sclerosis	0.000228	0.000397	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CD86—multiple sclerosis	0.000227	0.000397	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—MAPK1—multiple sclerosis	0.000226	0.000394	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RPL5—multiple sclerosis	0.000224	0.000391	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL5—multiple sclerosis	0.000224	0.00039	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—POMC—multiple sclerosis	0.000223	0.000388	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—TYK2—multiple sclerosis	0.000222	0.000388	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFIH1—multiple sclerosis	0.000221	0.000385	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRF8—multiple sclerosis	0.000221	0.000385	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-G—multiple sclerosis	0.000221	0.000385	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CD86—multiple sclerosis	0.00022	0.000383	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000219	0.000382	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CNR1—multiple sclerosis	0.000219	0.000382	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000217	0.000379	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL5—multiple sclerosis	0.000216	0.000377	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SLC11A1—multiple sclerosis	0.000215	0.000375	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HLA-B—multiple sclerosis	0.000212	0.00037	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RGS1—multiple sclerosis	0.000211	0.000368	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00021	0.000367	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—IL2—multiple sclerosis	0.00021	0.000366	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SPP1—multiple sclerosis	0.000207	0.000362	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TNFAIP3—multiple sclerosis	0.000207	0.00036	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—POMC—multiple sclerosis	0.000202	0.000353	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCR5—multiple sclerosis	0.000202	0.000352	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SPP1—multiple sclerosis	0.0002	0.000349	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GPR65—multiple sclerosis	0.0002	0.000349	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000199	0.000347	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000199	0.000347	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCL2—multiple sclerosis	0.000198	0.000345	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000197	0.000344	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL2—multiple sclerosis	0.000197	0.000344	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL10—multiple sclerosis	0.000197	0.000344	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCR5—multiple sclerosis	0.000195	0.00034	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000195	0.00034	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2RA—multiple sclerosis	0.000192	0.000335	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL2—multiple sclerosis	0.00019	0.000332	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—IL6—multiple sclerosis	0.000188	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD28—multiple sclerosis	0.000186	0.000324	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—STAT3—multiple sclerosis	0.000183	0.00032	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—APOE—multiple sclerosis	0.000183	0.00032	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR1—multiple sclerosis	0.000183	0.000319	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL13—multiple sclerosis	0.000183	0.000319	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CCR2—multiple sclerosis	0.000182	0.000318	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTPRC—multiple sclerosis	0.000182	0.000318	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL3—multiple sclerosis	0.000182	0.000317	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—TLR4—multiple sclerosis	0.00018	0.000314	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—TYK2—multiple sclerosis	0.00018	0.000313	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000179	0.000313	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—APOE—multiple sclerosis	0.000177	0.000309	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000177	0.000308	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-DPB1—multiple sclerosis	0.000176	0.000308	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MMP9—multiple sclerosis	0.000175	0.000306	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTGER4—multiple sclerosis	0.000175	0.000305	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—multiple sclerosis	0.000173	0.000302	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PGR—multiple sclerosis	0.000172	0.000301	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CD86—multiple sclerosis	0.000172	0.000301	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD28—multiple sclerosis	0.000172	0.000299	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ITGA4—multiple sclerosis	0.00017	0.000296	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD40—multiple sclerosis	0.00017	0.000296	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL5—multiple sclerosis	0.00017	0.000296	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000169	0.000295	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNB1—multiple sclerosis	0.000168	0.000294	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CD28—multiple sclerosis	0.000167	0.000292	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTLA4—multiple sclerosis	0.000167	0.000292	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—MAPK1—multiple sclerosis	0.000167	0.000291	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD80—multiple sclerosis	0.000166	0.00029	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CD80—multiple sclerosis	0.000166	0.000289	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL2—multiple sclerosis	0.000165	0.000287	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR2—multiple sclerosis	0.000164	0.000287	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CD80—multiple sclerosis	0.00016	0.000279	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TYK2—multiple sclerosis	0.000159	0.000277	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—POMC—multiple sclerosis	0.000158	0.000275	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SPP1—multiple sclerosis	0.000157	0.000274	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000154	0.000269	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL2—multiple sclerosis	0.000154	0.000269	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCR5—multiple sclerosis	0.000153	0.000267	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—POMC—multiple sclerosis	0.000152	0.000266	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CNR1—multiple sclerosis	0.000152	0.000265	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000151	0.000263	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2RA—multiple sclerosis	0.000151	0.000263	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2—multiple sclerosis	0.000149	0.000261	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL2—multiple sclerosis	0.000149	0.00026	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—VCAM1—multiple sclerosis	0.000148	0.000257	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-DQA1—multiple sclerosis	0.000147	0.000257	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000146	0.000254	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MAPK1—multiple sclerosis	0.000142	0.000247	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—TYK2—multiple sclerosis	0.00014	0.000245	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—POMC—multiple sclerosis	0.00014	0.000244	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TYK2—multiple sclerosis	0.00014	0.000244	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APOE—multiple sclerosis	0.000139	0.000243	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-DQB1—multiple sclerosis	0.000138	0.00024	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—BCHE—multiple sclerosis	0.000137	0.00024	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000137	0.000239	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000137	0.000238	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TYK2—multiple sclerosis	0.000135	0.000236	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD86—multiple sclerosis	0.000133	0.000231	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL3—multiple sclerosis	0.00013	0.000228	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD40LG—multiple sclerosis	0.00013	0.000227	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD8A—multiple sclerosis	0.000129	0.000224	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—multiple sclerosis	0.000128	0.000224	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD4—multiple sclerosis	0.000127	0.000221	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CD80—multiple sclerosis	0.000126	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTGER4—multiple sclerosis	0.000126	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP9—multiple sclerosis	0.000125	0.000218	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000124	0.000217	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-B—multiple sclerosis	0.000124	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PGR—multiple sclerosis	0.000124	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD86—multiple sclerosis	0.000122	0.000214	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCR3—multiple sclerosis	0.000121	0.000212	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CD28—multiple sclerosis	0.00012	0.00021	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CD86—multiple sclerosis	0.000119	0.000208	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—POMC—multiple sclerosis	0.000119	0.000208	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR2—multiple sclerosis	0.000118	0.000206	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL5—multiple sclerosis	0.000118	0.000205	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL2—multiple sclerosis	0.000117	0.000204	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—multiple sclerosis	0.000116	0.000203	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—multiple sclerosis	0.000116	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2RA—multiple sclerosis	0.000116	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-A—multiple sclerosis	0.000115	0.0002	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000114	0.000199	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000114	0.000199	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—multiple sclerosis	0.000112	0.000196	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—multiple sclerosis	0.000112	0.000195	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—STAT3—multiple sclerosis	0.000111	0.000194	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—multiple sclerosis	0.00011	0.000192	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SPP1—multiple sclerosis	0.000109	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CNR1—multiple sclerosis	0.000109	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—multiple sclerosis	0.000109	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CCR5—multiple sclerosis	0.000109	0.000189	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—multiple sclerosis	0.000107	0.000187	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—multiple sclerosis	0.000106	0.000186	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TYK2—multiple sclerosis	0.000106	0.000185	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR5—multiple sclerosis	0.000106	0.000185	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HLA-A—multiple sclerosis	0.000106	0.000185	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TLR4—multiple sclerosis	0.000105	0.000183	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-DRB1—multiple sclerosis	0.000105	0.000183	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	0.000105	0.000183	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000104	0.000182	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—multiple sclerosis	0.000104	0.000181	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—multiple sclerosis	0.000103	0.00018	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MAPK1—multiple sclerosis	0.000101	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ICAM1—multiple sclerosis	0.0001	0.000175	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOE—multiple sclerosis	9.87e-05	0.000172	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT3—multiple sclerosis	9.8e-05	0.000171	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL10—multiple sclerosis	9.8e-05	0.000171	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD80—multiple sclerosis	9.67e-05	0.000169	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOE—multiple sclerosis	9.63e-05	0.000168	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—multiple sclerosis	9.62e-05	0.000168	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—multiple sclerosis	9.56e-05	0.000167	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT3—multiple sclerosis	9.47e-05	0.000165	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MAPK1—multiple sclerosis	9.35e-05	0.000163	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—multiple sclerosis	9.11e-05	0.000159	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—multiple sclerosis	9.08e-05	0.000159	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD80—multiple sclerosis	8.93e-05	0.000156	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK1—multiple sclerosis	8.92e-05	0.000156	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK1—multiple sclerosis	8.91e-05	0.000155	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—multiple sclerosis	8.83e-05	0.000154	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—multiple sclerosis	8.8e-05	0.000154	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—multiple sclerosis	8.78e-05	0.000153	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—multiple sclerosis	8.77e-05	0.000153	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CD80—multiple sclerosis	8.71e-05	0.000152	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK1—multiple sclerosis	8.6e-05	0.00015	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CD86—multiple sclerosis	8.57e-05	0.00015	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL5—multiple sclerosis	8.44e-05	0.000147	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—multiple sclerosis	8.35e-05	0.000146	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—POMC—multiple sclerosis	8.28e-05	0.000144	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOE—multiple sclerosis	8.27e-05	0.000144	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TYK2—multiple sclerosis	8.16e-05	0.000142	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL2—multiple sclerosis	8.1e-05	0.000141	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—MAPK1—multiple sclerosis	7.92e-05	0.000138	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SPP1—multiple sclerosis	7.81e-05	0.000136	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—multiple sclerosis	7.76e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNG—multiple sclerosis	7.64e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR5—multiple sclerosis	7.6e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TYK2—multiple sclerosis	7.54e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2RA—multiple sclerosis	7.49e-05	0.000131	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT3—multiple sclerosis	7.43e-05	0.00013	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD4—multiple sclerosis	7.38e-05	0.000129	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TYK2—multiple sclerosis	7.35e-05	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—POMC—multiple sclerosis	7.1e-05	0.000124	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOE—multiple sclerosis	6.91e-05	0.000121	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—multiple sclerosis	6.9e-05	0.00012	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—multiple sclerosis	6.88e-05	0.00012	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—multiple sclerosis	6.85e-05	0.00012	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—multiple sclerosis	6.85e-05	0.000119	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—multiple sclerosis	6.82e-05	0.000119	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD4—multiple sclerosis	6.82e-05	0.000119	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—multiple sclerosis	6.79e-05	0.000119	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK1—multiple sclerosis	6.75e-05	0.000118	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—multiple sclerosis	6.61e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—multiple sclerosis	6.48e-05	0.000113	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CD80—multiple sclerosis	6.25e-05	0.000109	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—multiple sclerosis	6.12e-05	0.000107	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—multiple sclerosis	6.09e-05	0.000106	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—POMC—multiple sclerosis	5.94e-05	0.000104	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL2—multiple sclerosis	5.81e-05	0.000101	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—multiple sclerosis	5.79e-05	0.000101	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STAT3—multiple sclerosis	5.72e-05	9.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TYK2—multiple sclerosis	5.28e-05	9.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STAT3—multiple sclerosis	5.28e-05	9.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK1—multiple sclerosis	5.2e-05	9.07e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—multiple sclerosis	5.19e-05	9.05e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT3—multiple sclerosis	5.15e-05	8.99e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—multiple sclerosis	4.9e-05	8.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—multiple sclerosis	4.89e-05	8.54e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAPK1—multiple sclerosis	4.8e-05	8.37e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—multiple sclerosis	4.78e-05	8.35e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—multiple sclerosis	4.77e-05	8.33e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK1—multiple sclerosis	4.68e-05	8.17e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—multiple sclerosis	4.39e-05	7.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—multiple sclerosis	4.16e-05	7.25e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—multiple sclerosis	3.99e-05	6.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT3—multiple sclerosis	3.7e-05	6.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—multiple sclerosis	3.69e-05	6.43e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—multiple sclerosis	3.6e-05	6.28e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—multiple sclerosis	3.43e-05	5.99e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—multiple sclerosis	3.43e-05	5.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK1—multiple sclerosis	3.36e-05	5.86e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—multiple sclerosis	2.58e-05	4.5e-05	CbGpPWpGaD
